Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52

Details for Australian Patent Application No. 2005253723 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Wettendorff, Martine Anne Cecile; Stephenne, Jean; Debrus, Serge; Stephen, Robert John; Martin, MarieTherese

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005253723

PCT Pub. Number WO2005/123125

Priority 0413510.9 16.06.04 GB; 11/114,301 26.04.05 US

Filing date 14 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 20 January 2011

International Classifications

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123125 Priority application(s): WO2005/123125

20 January 2011 Application Accepted

  Published as AU-B-2005253723

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005253725-Protectant for controlling phytopathogenic fungi

2005253722-Self-foaming liquid creamers and processes